EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹9.04 Cr | ₹41 Cr | ₹-60 Cr | ₹-73 Cr | ₹-108 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of EMCURE PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹9.04 Cr |
| Mar2024 | ₹41 Cr |
| Mar2023 | ₹-60 Cr |
| Mar2022 | ₹-73 Cr |
| Mar2021 | ₹-108 Cr |
How is Deferred Tax Assets / Liabilities of EMCURE PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.04 Cr | -77.74 | |
| Mar2024 | ₹41 Cr | Positive | |
| Mar2023 | ₹-60 Cr | Negative | |
| Mar2022 | ₹-73 Cr | Negative | |
| Mar2021 | ₹-108 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹34,869.7 Cr | 4.9% | 5.8% | 35.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,803.0 Cr | 2.8% | 1.8% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,219.0 Cr | -0.2% | -0.1% | 3.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,417.0 Cr | 1.4% | -1.5% | 39.9% | Stock Analytics | |
| CIPLA | ₹116,116.0 Cr | 6% | 1.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,874.0 Cr | 4.8% | -0.3% | -0.9% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 4.9% |
5.8% |
35.6% |
| SENSEX | -0.2% |
2.1% |
-5.6% |
You may also like the below Video Courses